Growing Investments in Cancer Research
The rise in acquired resistance against systemic therapies is constantly happening due to the generation of variant cancer cells which leads to, the inability to cure advanced cancer patients. Circulating tumor cells are gaining increasing clinical attention because they may enable the monitoring cancer progression and adjustment of treatment. In recent years multiple technologies for enrichment, isolation as well as molecular and functional analysis of circulating tumor cells have been developed such as single cell analysis. Implementation of technologies like single cell analysis in standardized and automated workflows in clinical diagnostics could provide valuable information for real-time monitoring of cancer and eventually new therapeutic strategies for the benefit of patients. This will eventually lead to more efficient and better analysis. This will lead to the growth of this market. Other factors that will lead this market to grow include technological advancements in single-cell analysis products, growing biotechnology and biopharmaceutical industries, wide applications of single-cell analysis in cancer research, growing focus on personalized medicine and increasing incidence and prevalence of chronic and infectious diseases.
High Cost of Single-Cell Analysis Products
Recently there have been huge technological development in the field of transcriptomics have enabled unprecedented insight into about the molecular scale at the level of single cells. Single cell transcriptomics enables the measurement of transcriptomic information of thousands of single cells in a single experiment. The volume and complexity of resulting data make it a paradigm of big data. Consequently, the field is presented with new scientific and, in particular, analytical challenges where currently no scalable solutions exist. This opens up a requirement for huge investments and therefore make this kind of testing expensive and inaccessible to most of the patients. This will act as a restraint for the growth of the single cell analysis market.
Asia-Pacific to Emerge as the Fastest Growing Region
North America will dominate the market in the forecast period, followed by Europe and Asia-Pacific. However, the market in Asia-Pacific is expected to register the highest CAGR during the forecast period. The large population in China and India, rising geriatric population, and increasing incidence of chronic diseases are the major factors driving the growth of the Asian market.
Key Developments in the Market:
- June 2016 - Single-Cell RNA Sequencing Reveals Neuronal Diversity. Using a new approach to analyze the transcriptomes of thousands of individual cell nuclei in postmortem brains, researchers identify multiple neuronal subtypes.
Reasons to Purchase the Report
- Current and future single cell analysis market outlook in the developed and emerging markets
- Analysis of various perspectives of the market with the help of Porter’s five forces analysis
- The segment that is expected to dominate the market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, market shares, and strategies employed by the major market players
- 3 months analyst support, along with the Market Estimate sheet (in Excel)
This report can be customized to meet your requirements. Please connect with our Customer Service team, who will ensure you to get a report that suits your needs.
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry within the Industry
6 Drivers, Restraints, Opportunities and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Technological Advancements in Single-Cell Analysis Products
6.1.2 Growing Investments in Cancer Research
6.1.3 Growing Biotechnology and Biopharmaceutical Industries
6.1.4 Wide Applications of Single-Cell Analysis in Cancer Research
6.1.5 Growing Focus on Personalized Medicine
6.1.6 Increasing Incidence and Prevalence of Chronic and Infectious Diseases
6.2 Market Restraints
6.2.1 High Cost of Single-Cell Analysis Products
6.4 Key Challenges
7 Market Segmentation
7.1 By Cell Type
7.1.1 Human Cells
7.1.2 Animal Cells
7.1.3 Microbial Cells
7.2 By Technique
7.2.1 Flow Cytometry
7.2.2 Next-Generation Sequencing
7.2.3 Polymerase Chain Reaction
7.2.5 Mass Spectrometry
7.3 By Application
7.3.1 Research Applications
7.3.2 Cancer Research
7.4 Immunology Research
7.4.1 Neurology Research
7.4.2 Stem Cell Research
7.5.1 Non-Invasive Prenatal Diagnosis
18.104.22.168 In Vitro Fertilization
22.214.171.124 Circulating Tumor Cell Detection
126.96.36.199 By End User
7.5.3 Academic & Research Laboratories
188.8.131.52 Biotechnology and Pharmaceutical Companies
184.108.40.206 Hospitals and Diagnostic Laboratories
220.127.116.11 Cell Banks and IVF Centers
7.5.4 By Geography
18.104.22.168 North America
22.214.171.124 United States
126.96.36.199 United Kingdom
188.8.131.52 Rest of Europe
184.108.40.206 South Korea
220.127.116.11 Rest of Asia-Pacific
7.5.4 Middle East & Africa
18.104.22.168 South Africa
22.214.171.124 Rest of Middle East & Africa
7.5.5 South America
126.96.36.199 Rest of South America
8 Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9 Key Players
9.1 Agilent Technologies
9.2 Beckman Coulter, Inc. (A Subsidiary of Danaher Corporation)
9.3 Becton, Dickinson and Company
9.4 Bio-Rad Laboratories, Inc.
9.5 Fluidigm Corporation
9.6 GE Healthcare
9.7 Illumina, Inc.
9.8 Merck KGaA
9.9 Qiagen N.V.
9.10 Thermo Fisher Scientific, Inc.
*List Not Exhaustive
10 Future of the Market
- Agilent Technologies
- Beckman Coulter Inc. (A Subsidiary Of Danaher Corporation)
- Dickinson And Company
- Bio-Rad Laboratories Inc.
- Fluidigm Corporation
- Ge Healthcare
- Illumina Inc.
- Merck Kgaa
- Qiagen N.V.
- Thermo Fisher Scientific Inc.